BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kang NL, Zhang JM, Lin MX, Chen XD, Huang ZX, Zhu YY, Liu YR, Zeng DW. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients. World J Gastroenterol 2020; 26(27): 3952-3962 [PMID: 32774069 DOI: 10.3748/wjg.v26.i27.3952]
URL: https://www.wjgnet.com/1007-9327/full/v26/i27/3952.htm
Number Citing Articles
1
Hairong Yao, Xuan Yang, Man Yan, Xueqin Fang, Yange Wang, Hong Qi, Li Sun, Min Tang. Correlation of Serum M-CSF, CER, and TIMP-1 Levels with Liver Fibrosis in Viral HepatitisComputational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/6736225
2
Jiaming Teng, Yanan Du, Phimphone Visalath, Tianhui Zhou, Bingying Du, Qin Zhang, Wei Cai. A noninvasive model discriminating significant histological changes in treatment-naive chronic hepatitis B patients with normal ALTVirology Journal 2023; 20(1) doi: 10.1186/s12985-023-01963-x
3
J. Cao, X. Qi, N. Wang, Y. Chen, B. Xie, C. Ma, Z. Chen, W. Xiong. Ceruloplasmin regulating fibrosis in orbital fibroblasts provides a novel therapeutic target for Graves’ orbitopathyJournal of Endocrinological Investigation 2023; 46(10): 2005 doi: 10.1007/s40618-023-02033-3
4
Zeyu Wang, Yonghe Zhou, Pengzhi Yu, Yonggang Liu, Mei Mei, Zhuo Bian, Wei Shao, Jinxia Lv, Xin Li, Wei Lu, Liang Xu. Retrospective Evaluation of Non-Invasive Assessment Based on Routine Laboratory Markers for Assessing Advanced Liver Fibrosis in Chronic Hepatitis B PatientsInternational Journal of General Medicine 2022; : 5159 doi: 10.2147/IJGM.S364216
5
Ming Jian Lian, Zhi Qi Chen, Qian Ming Wang, Gang Sen Zheng, Guo Lin Hong. Diagnostic accuracy of mac‐2‐binding protein glycosylation isomer for diagnosing hepatitis B‐related fibrosis: A meta‐analysisJournal of Digestive Diseases 2022; 23(10): 550 doi: 10.1111/1751-2980.13140
6
Qingling Wang, Da Zhou, Mingjie Wang, Mingyu Zhu, Peizhan Chen, Hu Li, Meng Lu, Xinxin Zhang, Xizhong Shen, Taotao Liu, Li Chen. A Novel Non-Invasive Approach Based on Serum Ceruloplasmin for Identifying Non-Alcoholic Steatohepatitis Patients in the Non-Diabetic PopulationFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.900794